verified SJR 1,647 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · John Wiley and Sons Inc

workspace_premium Q1 — Hematology lock_open Open Access

British Journal of Haematology

British Journal of Haematology is a journal indexed in SJR in Hematology with an H index of 215. It has a price of 3000 €. It has an SJR impact factor of 1,647 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,647.

British Journal of Haematology focuses its scope in these topics and keywords: patients, cell, leukaemia, paediatric, cells, deficiency, stem, human, bcell, blood, ...

ISSN: 0007-1048

Publisher: John Wiley and Sons Inc

Category: Hematology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,647 Q1

H-index 215

Acceptance rate pie_chart

20% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

3.000 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,647

H-index

215

Docs (year)

724

Docs 3y

1919

Total refs

20784

Cites 3y

5244

Citable 3y

1108

Cites/Doc 2y

2.55

Ref/Doc

28.71

Immediate OA

3000 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Carboxy-terminal peptides (C1-24 and C13-24 but not C1-13) of platelet factor 4 inhibit murine megakaryocytopoiesis, an activity which is neutralized by heparin

Ultrastructural changes during adhesion and migration of pre-B lymphoid leukaemia cells within bone marrow stroma

Development and clinical application of a new ELISA assay to determine plasmin-a

Denaturing gradient gel electrophoresis: a novel method for determining Rh phenotype from genomic DNA

Cytomegalovirus-induced thrombocytopenia and haemolysis in an immunocompetent adult

Current approaches in the management of low risk Hodgkin lymphoma in children and adolescents

Cryopreserved Human Bone Marrow Stroma is Fully FunctionalIn vitro

Correlations between the intensity of fMLP-dependent respiratory burst and cellular fatty acid composition in human neutrophils

Constitutive expression of granulocyte-colony stimulating factor receptor on a human B-lymphoblastoid cell line

Constitutional pericentric inversion of chromosome 9 and bone marrow transplantation

ChlVPP chemotherapy in children with stage IV Hodgkin's disease: results of the UKCCSG HD 8201 and HD 9201 studies

Changes in the pattern of TCR Vbeta repertoire expression after bone marrow transplant is linked to the HLA haplotype in humans

SHOW MORE ARTICLES

CD30 ligand is expressed on resting normal and malignant human B lymphocytes

2-[18] Fluoro-2-deoxy-d-glucose positron emission tomography imaging in non-secretory multiple myeloma

Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): association with malignant transformation

Bleeding disorder due to platelet prostaglandin H synthase-1 (PGHS-1) deficiency

Autologous stem cell transplantation: evaluation of erythropoietic reconstitution by highly fluorescent reticulocyte counts, erythropoietin, soluble transferrin receptors, ferritin, TIBC and iron dosages

An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand

All-trans retinoic acid skews monocyte differentiationinto interleukin-12-secreting dendritic-like cells

Activity of the ligand forc-mpl, thrombopoietin, in early haemopoiesis

Activated protein C sensitivity ratio in pregnant women at delivery

Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies

A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation

FAQs

British Journal of Haematology has an SJR of 1,647 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 3000 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for British Journal of Haematology is 20%.

British Journal of Haematology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of British Journal of Haematology?

What is the APC / publication cost?

What is the acceptance rate?